A Cutting-Edge Cancer Treatment Is Under FDA Investigation—for Cancer Risk
WIRED Science - Ein Podcast von WIRED
Kategorien:
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers. Read this story here. Learn more about your ad choices. Visit megaphone.fm/adchoices
